Publication | Open Access

Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis

Vivo Antileishmanial ActivityAntiparasitic AgentMedicineParasitic ProtozoaImmunologyAcarbose PresentsPharmacologyVisceral LeishmaniasisParasitologyDrug Discovery